New in Vitro Toxicology Application for DRAQ5
This is the first demonstration of DRAQ5 to show drug-induced intracellular accumulation of (phospho)lipid vesicles in addition to providing information, as a live cell DNA reporter, on nuclear morphology and cell numbers.
This seminal work demonstrates a new inherent characteristic in DRAQ5 that lends new opportunities to the area of in vitro toxicology within drug development.
Biostatus Ltd.
+44(0)1509 558163
enquiry@biostatus.com
http://www.biostatus.com/news/draq5_in_vitro_tox_application/
PRESS CONTACT:
Roy Edward
Sales & Mktg. Director, Biostatus Ltd
TEL: +44(0)1509 558163; roy@biostatus.com; www.biostatus.com
Co. 3079239. Regd. in England & Wales. Regd. office: 56 Charnwood Road, Shepshed, LE12 9NP, UK.
Posted: September 2008
